BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Jury Awards $52 Million in Damages to Promega Corporation


2/16/2012 6:39:52 AM

MADISON, Wis.--(BUSINESS WIRE)--Today, in the United States District Court for the Western District of Wisconsin, a jury awarded $52,009,941 in damages to Promega Corporation (Madison, WI) for infringing sales by Life Technologies (Carlsbad, CA). The jury also found the infringing sales were made willfully. The Court may increase the final damage amount in light of the willfulness verdict. The Court also set a schedule to consider an injunction against Life Technologies for their sales of infringing products.

In November 2011 the Court’s ruling on Summary Judgment confirmed the validity of Promega Short Tandem Repeat (STR) patents, and found direct infringement by Life Technologies due to their sale of STR kits.

“The Court’s ruling and the jury award confirm the value of Promega STR technology and its contributions to genetic analysis in the fields of research and molecular diagnostics,” says Bill Linton, Promega CEO.

Promega’s pioneering STR technology is used worldwide in a number of applications for genetic analysis beyond forensics and paternity testing, including genetic research, cell line authentication, bone marrow transplantation monitoring, forensic training, and various types of cancer analysis.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Contacts

Promega Corporation

Penny Patterson, (608) 274-4330

Director, Corporate Affairs

penny.patterson@promega.com



Read at BioSpace.com
Read at BusinessWeek
Read at News Release
Read at Journal Sentinel

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES